Hepatitis C: diagnosis and treatment

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Hepatitis C is a prevalent chronic bloodborne infection in the US, affecting about 2% of adults.
• Chronic hepatitis C virus infection leads to significant morbidity and mortality, including cirrhosis and hepatocellular carcinoma.
• Current guidelines recommend testing for at-risk populations but not routine screening for asymptomatic, low-risk adults.

Purpose of the Study:

• To summarize current recommendations and therapeutic strategies for Hepatitis C virus (HCV) infection.
• To highlight the importance of testing for at-risk populations and managing chronic infection.
• To provide guidance on preventing complications and co-infections.

Main Methods:

• Review of current clinical guidelines and therapeutic approaches for Hepatitis C.
• Analysis of recommendations for screening and diagnosis.
• Summary of treatment goals and patient management strategies.

Main Results:

• Testing for Hepatitis C is advised for at-risk individuals, with polymerase chain reaction for viral quantification.
• The U.S. Preventive Services Task Force advises against routine screening in the general population.
• Current therapy involves pegylated interferon and ribavirin to slow fibrosis progression and prevent cirrhosis.

Conclusions:

• Management of chronic Hepatitis C focuses on slowing disease progression and preventing cirrhosis.
• Patients should abstain from alcohol and be vaccinated against Hepatitis A and B.
• Ultrasound surveillance for hepatocellular carcinoma is recommended for patients with cirrhosis.